Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Advances in the treatment of myocardial fibrosis by Tongxinluo Capsule
Hits 1181  Download times 939  Received:December 30, 2019  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2020.05.21
Key Words   Tongxinluo Capsule;vessel-collateral theory;myocardial fibrosis;endothelial to mesenchymal transition;microcirculation
Author NameAffiliationE-mail
LI Hongrong Hebei Yiling Hospital, State Administration of Traditional Chinese Medicine, Traditional Chinese Medicine Collaterology Key Discipline, Shijiazhuang 050091, China  
ZHAO Qifei Hebei Yiling Hospital, State Administration of Traditional Chinese Medicine, Traditional Chinese Medicine Collaterology Key Discipline, Shijiazhuang 050091, China  
YIN Yujie Hebei Yiling Medical Research Institute, Key Laboratory of State Administration of Traditional Chinese Medicine, Shijiazhuang 050035, China  
CHANG Liping State Key Laboratory of Collateral Disease Research and Innovation of Traditional Chinese Medicine, Shijiazhuang 050091, China  
JIA Zhenhua Hebei Yiling Hospital, State Administration of Traditional Chinese Medicine, Traditional Chinese Medicine Collaterology Key Discipline, Shijiazhuang 050091, China JZHjiazhenhua@163.com 
Abstract
    Myocardial fibrosis is a common pathological change from the development of many cardiovascular diseases to the terminal stage. Coronary microcirculation disturbance caused by various causes,as well as the ischemia,inflammation,endothelial interstitial transdifferentiation and so on,are the important inducements of myocardial fibrosis. The Vessel-Collateral theory holds that choroid stasis caused by various causes is the central link of myocardial fibrosis. Tongluo representative prescription Tongxinluo Capsule has the protective effect of blood,blood vessels and heart,and can significantly improve coronary microcirculation. It can significantly inhibit myocardial fibrosis caused by diabetes mellitus,myocardial infarction,myocarditis and so on,and can effectively improve cardiac function. Microcirculation disorder can also cause pulmonary fibrosis cirrhosis and systemic sclerosis and other diseases. Tongxinluo Capsule may play a role in inhibiting pulmonary fiber cirrhosis and systemic sclerosis by improving tissue microcirculation.

You are the 2309399 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.